関連する実験動画
がん患者における併発性メジャーうつ病に対する統合的共同治療 (SMaRT Oncology-2):多センターランダム化制御有効性試験
Michael Sharpe1, Jane Walker1, Christian Holm Hansen2
1Psychological Medicine Research, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, UK.
Lancet (London, England)
|September 2, 2014
まとめ
癌患者の統合うつ病ケアにより,通常のケアと比較して治療応答率が著しく改善されました. この協力的なアプローチは,生活の質を向上させ,腫瘍学の環境でうつ病の症状を軽減します.
科学分野:
- 腫瘍学 腫瘍学
- 精神科医は精神病を患っている.
- クリニック・トライアル 臨床試験
背景:
- 重度のうつ病は,しばしば病状を複雑化し,患者の生活の質を著しく損なう.
- がん患者はしばしば重度のうつ病を経験し,効果的な統合された治療戦略を必要とします.
研究 の 目的:
- 統合治療プログラムである"がん患者のうつ病ケア"の有効性を,がん患者の重度のうつ病に対する通常のケアと比較してみましょう.
主な方法:
- マルチセンター,ランダム化制御試験 (SMaRT Oncology-2) で,英国の3つのがんセンターの重度のうつ病患者さんを対象に実施した.
- 参加者はランダムに"がん患者のうつ病ケア"の介入または通常のケアに割り当てられました.
- 主要評価項は,治療への反応であり,24週目に症状チェックリストのうつ病スケール (SCL-20) のスコアが50%以上低下したと定義されています.
主要な成果:
- "がん患者のうつ病ケア"を受けている患者の62%が治療に反応し,通常のケアグループでは17%であった (絶対差は45%,p<0,0001).
- 統合ケアグループでは,鬱,不安,痛み,疲労が有意に減少し,機能と生活の質が改善されたと報告されています.
- 臨床試験に関連する有害事象は報告されず,がん関連の死亡や精神疾患は介入と関連していない.
結論:
- "がん患者のうつ病ケア"は,がん患者の重度のうつ病に対する効果的な治療法です.
- この統合された共同ケアモデルは,他の疾患と併発するうつ病の管理に有効なアプローチを提供します.
関連する概念動画
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Chronic Pancreatitis II: Collaborative Care
558
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
558
Depressive Disorders: MDD and Dysthymia
1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Acute Coronary Syndrome IV: Interprofessional Care
519
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
519